Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children (Q33319552)

25 July 2017

Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children (English)

1 reference

25 July 2017

0 references

1 reference

1 reference

11

Amagana Dolo

0 references

Michael P. Fay

object named as

Michael P Fay

13

0 references

Allan Saul

object named as

Allan Saul

16

0 references

Ogobara K. Doumbo

18

object named as

Ogobara K Doumbo

1 reference

25 July 2017

4

Kazutoyo Miura

1 reference

25 July 2017

1

Alassane Dicko

1 reference

25 July 2017

2

Issaka Sagara

1 reference

25 July 2017

5

Ousmane Guindo

1 reference

25 July 2017

15

Dapa A Diallo

1 reference

25 July 2017

3

Ruth D Ellis

1 reference

25 July 2017

17

Louis H Miller

1 reference

25 July 2017

7

Moussa Sogoba

1 reference

25 July 2017

6

Beh Kamate

1 reference

25 July 2017

10

Mounirou Baby

1 reference

25 July 2017

12

Gregory E D Mullen

1 reference

25 July 2017

14

Mark Pierce

1 reference

25 July 2017

Mohamed Balla Niambelé

8

1 reference

PubMed ID

18270560

25 July 2017

Mady Sissoko

9

1 reference

PubMed ID

18270560

25 July 2017

language of work or name

English

0 references

publication date

13 February 2008

1 reference

25 July 2017

1 reference

25 July 2017

3

1 reference

25 July 2017

2

1 reference

25 July 2017

e1563

1 reference

Creative Commons CC0 License

25 July 2017

start time

13 February 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

cites work

Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Malaria vaccines: are we getting closer?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

A review of human vaccine research and development: malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Random marginal agreement coefficients: rethinking the adjustment for chance when measuring agreement.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001563

Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2216433

10.1371/JOURNAL.PONE.0001563

31 October 2018

Identifiers

DOI

1 reference

25 July 2017

0 references

1 reference

25 July 2017

1 reference

PubMed ID

18270560